Allianz Technology Trust (LON:ATT) Reaches New 12-Month High - Here's What Happened

Key Points

• Allianz Technology Trust shares reached a new 52-week high of GBX 463.24 ($6.27) during trading, marking significant price activity with a volume of 842,060 shares.
• The company reported a return on equity of 34.32% with a net margin of 98.24%, indicating strong financial performance despite a recent earnings per share of GBX (0.42) (($0.01)).
• Managed by the AllianzGI Global Technology team located in Silicon Valley, the Trust focuses on long-term capital growth through investments in technology companies worldwide.

Allianz Technology Trust (LON:ATT - Get Free Report) shares hit a new 52-week high during trading on Friday . The stock traded as high as GBX 380.20 ($5.14) and last traded at GBX 463.24 ($6.27), with a volume of 842060 shares trading hands. The stock had previously closed at GBX 466 ($6.30).

Allianz Technology Trust Price Performance

The firm has a market capitalization of £1.76 billion, a price-to-earnings ratio of 3.50 and a beta of 0.52. The firm's 50-day simple moving average is GBX 436.27 and its 200 day simple moving average is GBX 402.72.

Allianz Technology Trust (LON:ATT - Get Free Report) last issued its quarterly earnings data on Monday, August 11th. The company reported GBX (0.42) (($0.01)) earnings per share for the quarter. Allianz Technology Trust had a return on equity of 34.32% and a net margin of 98.24%.

Allianz Technology Trust Company Profile

Allianz Technology Trust is managed by the highly experienced AllianzGI Global Technology team based in San Francisco. The team benefits from its close proximity to Silicon Valley where many of the world's key technology companies are headquartered. The Trust is a UK listed closed-end fund which aims to achieve long-term capital growth by investing principally in technology companies globally.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.